The early use of immunosuppression reduces morbidity in patients with moderately severe or severe Crohn's disease

Comment

Amandeep K Shergill et al. Gastroenterology. 2008 Oct.

. 2008 Oct;135(4):1417-20.

doi: 10.1053/j.gastro.2008.08.016. Epub 2008 Sep 4.

No abstract available

Comment on

Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial.
D'Haens G, Baert F, van Assche G, Caenepeel P, Vergauwe P, Tuynman H, De Vos M, van Deventer S, Stitt L, Donner A, Vermeire S, Van De Mierop FJ, Coche JR, van der Woude J, Ochsenkühn T, van Bodegraven AA, Van Hootegem PP, Lambrecht GL, Mana F, Rutgeerts P, Feagan BG, Hommes D; Belgian Inflammatory Bowel Disease Research Group; North-Holland Gut Club. D'Haens G, et al. Lancet. 2008 Feb 23;371(9613):660-667. doi: 10.1016/S0140-6736(08)60304-9. Lancet. 2008. PMID: 18295023 Clinical Trial.